423 related articles for article (PubMed ID: 29338956)
1. Gender Identity Disparities in Cancer Screening Behaviors.
Tabaac AR; Sutter ME; Wall CSJ; Baker KE
Am J Prev Med; 2018 Mar; 54(3):385-393. PubMed ID: 29338956
[TBL] [Abstract][Full Text] [Related]
2. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
Berzansky I; Reynolds CA; Charlton BM
Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
[TBL] [Abstract][Full Text] [Related]
3. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
Charkhchi P; Schabath MB; Carlos RC
J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
[TBL] [Abstract][Full Text] [Related]
4. Self-Reported Physical and Mental Health of Gender Nonconforming Transgender Adults in the United States.
Streed CG; McCarthy EP; Haas JS
LGBT Health; 2018 Oct; 5(7):443-448. PubMed ID: 30183498
[TBL] [Abstract][Full Text] [Related]
5. Gender and Frequent Mental Distress: Comparing Transgender and Non-Transgender Individuals' Self-Rated Mental Health.
Crissman HP; Stroumsa D; Kobernik EK; Berger MB
J Womens Health (Larchmt); 2019 Feb; 28(2):143-151. PubMed ID: 30615547
[TBL] [Abstract][Full Text] [Related]
6. Health Care Satisfaction in Relation to Gender Identity: Behavioral Risk Factor Surveillance Survey, 20 States (2014-2018).
Ferrucci KA; Walubita T; Beccia AL; Ding EY; Jesdale BM; Lapane KL; Streed CG
Med Care; 2021 Apr; 59(4):312-318. PubMed ID: 33492048
[TBL] [Abstract][Full Text] [Related]
7. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
8. Misclassification of Sex Assigned at Birth in the Behavioral Risk Factor Surveillance System and Transgender Reproductive Health: A Quantitative Bias Analysis.
Tordoff D; Andrasik M; Hajat A
Epidemiology; 2019 Sep; 30(5):669-678. PubMed ID: 31162292
[TBL] [Abstract][Full Text] [Related]
9. Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014-2017 BRFSS.
Caceres BA; Jackman KB; Edmondson D; Bockting WO
J Behav Med; 2020 Apr; 43(2):329-338. PubMed ID: 31559524
[TBL] [Abstract][Full Text] [Related]
10. Transgender individuals' cancer survivorship: Results of a cross-sectional study.
Boehmer U; Gereige J; Winter M; Ozonoff A; Scout N
Cancer; 2020 Jun; 126(12):2829-2836. PubMed ID: 32134515
[TBL] [Abstract][Full Text] [Related]
11. Looking at Population Health Beyond "Male" and "Female": Implications of Transgender Identity and Gender Nonconformity for Population Health.
Lagos D
Demography; 2018 Dec; 55(6):2097-2117. PubMed ID: 30255426
[TBL] [Abstract][Full Text] [Related]
12. Barriers to Care Among Transgender and Gender Nonconforming Adults.
Gonzales G; Henning-Smith C
Milbank Q; 2017 Dec; 95(4):726-748. PubMed ID: 29226450
[TBL] [Abstract][Full Text] [Related]
13. Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States.
Azagba S; Latham K; Shan L
Int J Drug Policy; 2019 Nov; 73():163-169. PubMed ID: 31353246
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.
Zhang WQ; Tang SJ; Dobbs TE; Zhang L
South Med J; 2020 Jul; 113(7):360-365. PubMed ID: 32617599
[TBL] [Abstract][Full Text] [Related]
15. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer Screening Eligibility and Utilization Among Transgender Patients: An Analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
Stowell JT; Parikh Y; Tilson K; Narayan AK
Nicotine Tob Res; 2020 Dec; 22(12):2164-2169. PubMed ID: 32623455
[TBL] [Abstract][Full Text] [Related]
17. Pap test use is lower among female-to-male patients than non-transgender women.
Peitzmeier SM; Khullar K; Reisner SL; Potter J
Am J Prev Med; 2014 Dec; 47(6):808-12. PubMed ID: 25455121
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Exposure to Intimate Partner Violence Among Transgender/Gender Nonconforming and Sexual Minority Primary Care Patients.
Valentine SE; Peitzmeier SM; King DS; O'Cleirigh C; Marquez SM; Presley C; Potter J
LGBT Health; 2017 Aug; 4(4):260-267. PubMed ID: 28719246
[TBL] [Abstract][Full Text] [Related]
19. Measuring the Health of an Invisible Population: Lessons from the Colorado Transgender Health Survey.
Christian R; Mellies AA; Bui AG; Lee R; Kattari L; Gray C
J Gen Intern Med; 2018 Oct; 33(10):1654-1660. PubMed ID: 29761263
[TBL] [Abstract][Full Text] [Related]
20. Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.
Sanford NN; Sher DJ; Butler S; Xu X; Ahn C; D'Amico AV; Rebbeck T; Aizer AA; Mahal BA
JAMA Netw Open; 2019 May; 2(5):e193759. PubMed ID: 31099863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]